Sun Chuan-zheng, Chen Fu-jin, Zeng Zong-yuan, Li Qiu-li, Chen Yan-feng, Song Ming
State Key laboratory of Oncology in Southern China, Departmemt of Head and Neck Surgery, Cancer Center, SUN Yat-sen University Guangzhou, China.
Zhonghua Zhong Liu Za Zhi. 2006 Dec;28(12):938-41.
To investigate the clinical characteristics and prognosis of second primary tumor of tongue (SPTr) after nasopharyngeal carcinoma (NPCR) treated with radiotherapy.
Clinical data of 53 patients with SP7T after NPCR (group A) and 252 patients with primary tongue carcinoma (group B) were analyzed retrospectively with regard to clinical characteristics and survival rate (Kaplan-Meier); and multivariate analysis was performed using Cox proportional hazards model.
There was no significant difference between group A and group B ( P > 0. 05) in the presenting age, sex, tumor size, cTNM stage, tumor differentiation and the rate of distant metastasis. The overall 5-year survival rates were 41.6% in group A and 56.3% in group B (chi2 = 4.40, P = 0.0359) with a statistically significant difference between two groups. The differences of tumor location (chi2 = 61.18, P = 0.000) and rate of clinical (cN+, chi2 = 6.846, P = 0.009) or pathological lymph node metastasis (pN+, X2 = 3.993, P = 0.046) were also statistically significant between group A and group B, respectively. Multivariate analysis showed that age at presence, cTNM stage and with or without neck lymph node dissection were independent risk factors affecting survival.
Second primary tongue carcinoma after radiotherapy for nasopharyngeal carcinoma is likely to occur on the dorsal aspect of the tongue with worse prognosis but with a lower rate of lymph node metastasis than that of primary tongue carcinoma. However, radiotherapy history is not an independent influencing factor on prognosis. Surgical resection or combined modality therapy may give a better prognosis.
探讨鼻咽癌放疗后舌部第二原发肿瘤(SPTr)的临床特征及预后。
回顾性分析53例鼻咽癌放疗后发生SPTr的患者(A组)和252例原发性舌癌患者(B组)的临床资料,比较其临床特征及生存率(Kaplan-Meier法);采用Cox比例风险模型进行多因素分析。
A组与B组在发病年龄、性别、肿瘤大小、cTNM分期、肿瘤分化程度及远处转移率方面差异无统计学意义(P>0.05)。A组5年总生存率为41.6%,B组为56.3%(χ2 = 4.40,P = 0.0359),两组差异有统计学意义。A组与B组在肿瘤部位(χ2 = 61.18,P = 0.000)、临床(cN+,χ2 = 6.846,P = 0.009)或病理淋巴结转移率(pN+,χ2 = 3.993,P =